Caitlin Raymond: Practicing at the Edge of ABO – Navigating Rare A Subgroups
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at the University of Wisconsin-Madison, shared on LinkedIn:
”I just published a new post on Blood, Bytes, and Beyond: “Practicing at the Edge of ABO: Navigating Rare A Subgroups.”
In transfusion medicine, we talk a lot about “weak A” phenotypes — but biologically and clinically, they’re not all the same.
A3, Aw, and Ael arise through different mechanisms, carry different degrees of antigen expression, and sit in very different evidence spaces when it comes to transfusion risk.
This piece grew out of a real on-service case, where the literature didn’t quite tell us what to do, and judgment mattered as much as data.
It’s a reflection on how we make conservative decisions when incidence data are sparse, case reports loom large, and the downside of being wrong is asymmetric.
If you work in transfusion medicine, blood banking, or laboratory medicine more broadly — or if you’re interested in how clinicians navigate uncertainty at the bedside — I’d love for you to read it.”
Read the full post here.
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke